Literature DB >> 1356357

Animal behavioural studies in the evaluation of antidepressant drugs.

M H Thiébot1, P Martin, A J Puech.   

Abstract

Animal behavioural models of psychiatric disorders cannot exactly simulate human psychopathology, but they can be used to evaluate the behavioural changes induced by drugs and to suggest hypotheses about the functions of the CNS and its involvement in psychiatric disorders. This should lead to a more heuristic classification of psychotropic drugs and to clarification of their therapeutic possibilities. The following animal models simulate aspects of depressive disorders and are sensitive to the antidepressant effects of drugs. (i) The forced swimming test: described as 'behavioural despair' on the assumption that the animal has given up hope of escaping. (ii) The 'restraint stress' test: this may indicate a failure to adapt to stress. (iii) The learned-helplessness model: exposed to uncontrollable events, animals exhibit learning performance deficit and behavioural changes, including decreased locomotor activity and loss of appetite. (iv) Waiting behaviour: improvement in the ability to wait for and/or postpone an active response; this could be related to the reported beneficial effects of antidepressants on impulsive behaviour.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356357

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN: 0960-5371


  15 in total

Review 1.  Examining antidepressant drug response by smoking status: why is it important and how often is it done?

Authors:  Andrea H Weinberger; Sherry A McKee; Marina R Picciotto; Carolyn M Mazure
Journal:  J Psychopharmacol       Date:  2010-12-17       Impact factor: 4.153

2.  Stressor-specific alterations in corticosterone and immune responses in mice.

Authors:  Stephanie L Bowers; Staci D Bilbo; Firdaus S Dhabhar; Randy J Nelson
Journal:  Brain Behav Immun       Date:  2007-09-24       Impact factor: 7.217

3.  Protective effects of Andrographis paniculata extract and pure andrographolide against chronic stress-triggered pathologies in rats.

Authors:  Ajit Kumar Thakur; Upendra Kumar Soni; Geeta Rai; Shyam Sunder Chatterjee; Vikas Kumar
Journal:  Cell Mol Neurobiol       Date:  2014-07-18       Impact factor: 5.046

4.  Effects of morphine, naloxone and their interaction in the learned-helplessness paradigm in rats.

Authors:  A Besson; A M Privat; A Eschalier; J Fialip
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

5.  Stress induces equivalent remodeling of hippocampal spine synapses in a simulated postpartum environment and in a female rat model of major depression.

Authors:  Judith Baka; Eszter Csakvari; Orsolya Huzian; Nikoletta Dobos; Laszlo Siklos; Csaba Leranth; Neil J MacLusky; Ronald S Duman; Tibor Hajszan
Journal:  Neuroscience       Date:  2016-12-22       Impact factor: 3.590

6.  Antistress, Adoptogenic Activity of Sida cordifolia Roots in Mice.

Authors:  Meera Sumanth; S S Mustafa
Journal:  Indian J Pharm Sci       Date:  2009-05       Impact factor: 0.975

7.  Treatment with escitalopram but not desipramine decreases escape latency times in a learned helplessness model using juvenile rats.

Authors:  Abbey L Reed; Jeffrey C Anderson; David B Bylund; Frederick Petty; Hesham El Refaey; H Kevin Happe
Journal:  Psychopharmacology (Berl)       Date:  2009-04-22       Impact factor: 4.530

Review 8.  Mechanism of action of St John's wort in depression : what is known?

Authors:  Veronika Butterweck
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

9.  VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants.

Authors:  Jennifer L Warner-Schmidt; Ronald S Duman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

Review 10.  The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation.

Authors:  B S McEwen; S Chattarji; D M Diamond; T M Jay; L P Reagan; P Svenningsson; E Fuchs
Journal:  Mol Psychiatry       Date:  2009-08-25       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.